Search research articles
Contact Us
Filters
Showing results (1-10 of 41) with videos related to
Page
of 5
Sort By:
Oncology (Williston Park, N.Y.)
|
February 5, 2010
Bone biology and the role of the RANK ligand pathway
Rashmi K Murthy, P K Morrow, Richard L Theriault
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 13, 2018
Genetic Counseling Referral Rates in Long-Term Survivors of Triple-Negative Breast Cancer
Carlos H Barcenas, Maryam N Shafaee, Arup K Sinha, et al.
Breast Cancer Research and Treatment
|
April 13, 2019
Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1)
Luis Baez-Vallecillo, Akshara S Raghavendra, Kenneth R Hess, et al.
JCO Clinical Cancer Informatics
|
February 17, 2022
Reply to A. Pfob and C. Sidey-Gibbons
Carlos H Barcenas, Juhee Song, Rashmi K Murthy, et al.
JCO Clinical Cancer Informatics
|
August 5, 2021
Prognostic Model for De Novo and Recurrent Metastatic Breast Cancer
Carlos H Barcenas, Juhee Song, Rashmi K Murthy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 6, 2017
Phase I Study of ONT-380, a HER2 Inhibitor, in Patients with HER2<sup>+</sup>-Advanced Solid Tumors, with an Expansion Cohort in HER2<sup>+</sup> Metastatic Breast Cancer (MBC)
Stacy L Moulder, Virginia F Borges, Tara Baetz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2018
Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer
Funda Meric-Bernstam, Amber M Johnson, Ecaterina E Ileana Dumbrava, et al.
Breast Cancer Research : BCR
|
December 31, 2014
Outcomes of children exposed in utero to chemotherapy for breast cancer
Rashmi K Murthy, Richard L Theriault, Chad M Barnett, et al.
Cancer
|
December 15, 2023
Survival outcomes of patients with HER2/neu-positive breast cancer with germline BRCA mutations
Fatma Nihan Akkoc Mustafayev, Mihir Amitabh Shukla, Amanda Lanier, et al.
NPJ Breast Cancer
|
March 29, 2020
Incorporation of clinical and biological factors improves prognostication and reflects contemporary clinical practice
Rashmi K Murthy, Juhee Song, Akshara S Raghavendra, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 41) with videos related to
Sort By:
Page
of 5
Oncology (Williston Park, N.Y.)
|
February 5, 2010
Bone biology and the role of the RANK ligand pathway
Rashmi K Murthy, P K Morrow, Richard L Theriault
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 13, 2018
Genetic Counseling Referral Rates in Long-Term Survivors of Triple-Negative Breast Cancer
Carlos H Barcenas, Maryam N Shafaee, Arup K Sinha, et al.
Breast Cancer Research and Treatment
|
April 13, 2019
Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1)
Luis Baez-Vallecillo, Akshara S Raghavendra, Kenneth R Hess, et al.
JCO Clinical Cancer Informatics
|
February 17, 2022
Reply to A. Pfob and C. Sidey-Gibbons
Carlos H Barcenas, Juhee Song, Rashmi K Murthy, et al.
JCO Clinical Cancer Informatics
|
August 5, 2021
Prognostic Model for De Novo and Recurrent Metastatic Breast Cancer
Carlos H Barcenas, Juhee Song, Rashmi K Murthy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 6, 2017
Phase I Study of ONT-380, a HER2 Inhibitor, in Patients with HER2<sup>+</sup>-Advanced Solid Tumors, with an Expansion Cohort in HER2<sup>+</sup> Metastatic Breast Cancer (MBC)
Stacy L Moulder, Virginia F Borges, Tara Baetz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2018
Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer
Funda Meric-Bernstam, Amber M Johnson, Ecaterina E Ileana Dumbrava, et al.
Breast Cancer Research : BCR
|
December 31, 2014
Outcomes of children exposed in utero to chemotherapy for breast cancer
Rashmi K Murthy, Richard L Theriault, Chad M Barnett, et al.
Cancer
|
December 15, 2023
Survival outcomes of patients with HER2/neu-positive breast cancer with germline BRCA mutations
Fatma Nihan Akkoc Mustafayev, Mihir Amitabh Shukla, Amanda Lanier, et al.
NPJ Breast Cancer
|
March 29, 2020
Incorporation of clinical and biological factors improves prognostication and reflects contemporary clinical practice
Rashmi K Murthy, Juhee Song, Akshara S Raghavendra, et al.
Page
of 5